The more affordable vials are marketed toward patients whose health insurance will not reimburse them for the cost of the drug.
Eli Lilly said it has started selling single-dose vials of its uber-popular weight-loss drug Zepbound as demand soars – and the smaller doses cost 50% less than rival drugs.
The more affordable vials are marketed toward patients whose health insurance will not reimburse them for weight-loss medications. The drugmaker said it will sell 2.5 milligram and 5 milligram vials – now the two lowest doses of Zepbound – for $399 and $549 for a month’s supply on its website, LillyDirect. Eli Lilly said it has started selling single-dose vials of its popular weight-loss drug — and they cost 50% less than other obesity medicines.Zepbound and Novo’s Wegovy have faced shortages for most of this year, according to the US Food and Drug Administration.
Talk show phenomenon Oprah Winfrey – who famously sat on the board of diet program WeightWatchers – made headlines when she revealed she was using a weight loss medication last year.Nvidia employees often work 7 days a week until 2 a.m. -- but here's why few of them leaveGarcelle Beauvais reveals son Jax no longer on ‘RHOBH’ after ‘horrible’ fan messages
Mariah Carey’s estranged sister, Alison, was on hospice care before dying on the same day as their momEli Lilly said it has started selling single-dose vials of its popular weight-loss drug -- and they cost 50% less than other obesity medicines.Eli Lilly raised its sales forecast for the year by $3 billion on improved manufacturing and increased supplies of its weight loss drug.
Diabetes Obesity Ozempic Weight Loss
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly cuts cost of certain Zepbound doses by at least 50%Eli Lilly is launching more supply of its weight loss drug Zepbound. The new single-dose vials will be priced lower than 'all other incretin GLP-1 medicines for obesity.'
Read more »
Eli Lilly lowers Zepbound price and Harris campaign hits Trump on fiscal agenda: Morning RundownBlockbuster drugs Ozempic and Wegovy have sparked conversation and changed weight loss worldwide. In an exclusive interview, NBC News’ Megan Fitzgerald sits down with Novo Nordisk CEO Lars Fruergaard Jørgensen who helmed it all, and presses him on the high price, drug shortages, and long-term effects.
Read more »
Zepbound price cut: Eli Lilly lowers cost of weight loss drugBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »
Eli Lilly slashes prices of weight-loss drug Zepbound for single-use vialsThe cheaper drug will compete with compounded versions of the same medication sold by digital health companies.
Read more »
Eli Lilly to sell Zepbound directly to consumers without insurance coverageEli Lilly is announcing a new way for people to get its popular Zepbound drug.
Read more »
Eli Lilly's Zepbound reduces type 2 diabetes risk, study showsEli Lilly announced results of a study in which weekly shots of tirzepatide injections significantly reduced the risk of progression to type 2 diabetes by 94% among certain adults.
Read more »